The 20 Best Metastatic Insulinoma Doctors Near Me in Michigan, US

Richard Zekman is an Oncologist in Royal Oak, Michigan. Dr. Zekman has been practicing medicine for over 23 years and is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy. Dr. Zekman is currently accepting new patients.

Laura Nadeau is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Nadeau has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Adult Immune Thrombocytopenia, Chronic Familial Neutropenia, and Bone Marrow Aspiration. Dr. Nadeau is currently accepting new patients.

Mitchell Folbe is an Oncologist in Sterling Heights, Michigan. Dr. Folbe has been practicing medicine for over 34 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Hemochromatosis, Angiosarcoma, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Folbe is currently accepting new patients.

Howard Korman is a Urologist in Royal Oak, Michigan. Dr. Korman has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Urinary Tract Infection (UTI), Kidney Stones, Perirenal Abscess, Lithotripsy, and Prostatectomy. Dr. Korman is currently accepting new patients.

Mohammad Alhyari is a Hematologist and a Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Alhyari has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Alhyari is currently accepting new patients.

Savitha Balaraman is an Oncologist in Royal Oak, Michigan. Dr. Balaraman has been practicing medicine for over 31 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Balaraman is currently accepting new patients.

Ishmael Jaiyesimi is a Hematologist Oncology provider in Royal Oak, Michigan. Dr. Jaiyesimi has been practicing medicine for over 40 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Jaiyesimi is currently accepting new patients.

Ala Shuker is a primary care provider, practicing in Internal Medicine in Livonia, Michigan. Dr. Shuker has been practicing medicine for over 35 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, Gastrostomy, and Endoscopy. Dr. Shuker is currently accepting new patients.

Philip Philip is an Oncologist in Detroit, Michigan. Dr. Philip is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Liver Embolization.

Michael Jacobs is a General Surgeon in Novi, Michigan. Dr. Jacobs is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Choledocholithiasis, Hernia, Gallstones, Pancreatectomy, and Small Bowel Resection.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Matthew Ryan is a Hematologist and an Oncologist in Escanaba, Michigan. Dr. Ryan is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Lung Adenocarcinoma, Acquired Hemophilia, Bone Marrow Aspiration, and Gastrostomy.

Brian Burnette is a Hematologist and an Oncologist in Escanaba, Michigan. Dr. Burnette is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Familial Colorectal Cancer, Familial Wilms Tumor 2, and Bone Marrow Aspiration.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Arathi Mohan is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Mohan has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Stomach Cancer.

Adam Forman is a Hematologist in Novi, Michigan. Dr. Forman is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Cholangiocarcinoma (Bile Duct Cancer), Paget Disease of the Breast, and Bone Marrow Aspiration.

Harmeshkumar Naik is an Oncologist in Brownstown Twp, Michigan. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pleuropulmonary Blastoma, Paget Disease of the Breast, Breast Cancer, and Muscle Invasive Bladder Cancer.

Ayham Ashkar is an Oncologist in Royal Oak, Michigan. Dr. Ashkar is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Gallbladder Adenocarcinoma, Bone Marrow Aspiration, and Endoscopy.

Michael Williams is a primary care provider, practicing in Internal Medicine in Southfield, Michigan. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Familial Hypertension, Coronary Heart Disease, Deep Vein Thrombosis, and Thyroid Storm.

Michael Zakem is an Internal Medicine provider in Grand Rapids, Michigan. Dr. Zakem is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Non-Hodgkin Lymphoma, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.